Skip to content

Asthma Care Improving


DENVER —

New medications introduced in the past decade appear to have improved asthma care and outcomes among children with severe asthma. After noticing a decline in the number of children to the National Jewish Health Pediatric Day Program for treatment of severe asthma, Joseph Spahn, MD, and his colleagues compared two cohorts of moderate-to-severe asthma patients from 1993-1997 and 2004-2007. They found that the recent patients had better lung function, less use of rescue medications, less use of oral steroids, and less weight gain. Dr. Spahn attributes the improved outcomes to more effective medications, including the better inhaled steroids, steroid/beta agonist combinations (i.e. Advair), and leukotriene modifying agents (i.e. Singulair). It is unclear, however, if the new medications are altering the long-term course of the disease.

National Jewish Health is the leading respiratory hospital in the nation. Founded 125 years ago as a nonprofit hospital, National Jewish Health today is the only facility in the world dedicated exclusively to groundbreaking medical research and treatment of children and adults with respiratory, cardiac, immune and related disorders. Patients and families come to National Jewish Health from around the world to receive cutting-edge, comprehensive, coordinated care. To learn more, visit the media resources page.


We have many faculty members, from bench scientists to clinicians, who can speak on almost any aspect of respiratory, immune, cardiac and gastrointestinal disease as well as lung cancer and basic immunology.


Our team is available to arrange interviews, discuss events and story ideas.